188 related articles for article (PubMed ID: 7737912)
21. Associated factors of atrophic gastritis diagnosed by double-contrast upper gastrointestinal barium X-ray radiography: a cross-sectional study analyzing 6,901 healthy subjects in Japan.
Yamamichi N; Hirano C; Shimamoto T; Minatsuki C; Takahashi Y; Nakayama C; Matsuda R; Fujishiro M; Konno-Shimizu M; Kato J; Kodashima S; Ono S; Niimi K; Mochizuki S; Tsuji Y; Sakaguchi Y; Asada-Hirayama I; Takeuchi C; Yakabi S; Kakimoto H; Wada R; Mitsushima T; Ichinose M; Koike K
PLoS One; 2014; 9(10):e111359. PubMed ID: 25343257
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori infection and markers of gastric cancer risk in Alaska Native persons: a retrospective case-control study.
Keck JW; Miernyk KM; Bulkow LR; Kelly JJ; McMahon BJ; Sacco F; Hennessy TW; Bruce MG
Can J Gastroenterol Hepatol; 2014 Jun; 28(6):305-10. PubMed ID: 24945184
[TBL] [Abstract][Full Text] [Related]
23. Is Helicobacter pylori a causal agent in gastric carcinoma?
Takahashi S; Igarashi H; Ishiyama N; Nakamura K; Masubuchi N; Ozaki M; Saito S; Aoyagi T; Itoh T; Hirata I
Zentralbl Bakteriol; 1993 Sep; 280(1-2):144-9. PubMed ID: 8280936
[TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori infection and genetic polymorphisms for cancer-related genes in gastric carcinogenesis.
Kato S; Onda M; Matsukura N; Tokunaga A; Matsuda N; Yamashita K; Shields PG
Biomed Pharmacother; 1997; 51(4):145-9. PubMed ID: 9207980
[TBL] [Abstract][Full Text] [Related]
25. Associations of a PTPN11 G/A polymorphism at intron 3 with Helicobactor pylori seropositivity, gastric atrophy and gastric cancer in Japanese.
Hishida A; Matsuo K; Goto Y; Naito M; Wakai K; Tajima K; Hamajima N
BMC Gastroenterol; 2009 Jul; 9():51. PubMed ID: 19589142
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg.
Roman LD; Lukyanchuk R; Sablin OA; Araslanova EI; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
Anticancer Res; 2016 Aug; 36(8):4129-38. PubMed ID: 27466521
[TBL] [Abstract][Full Text] [Related]
27. The clinical usefulness of serum pepsinogens, specific IgG anti-HP antibodies and gastrin for monitoring Helicobacter pylori treatment in older people.
Pilotto A; Franceschi M; Leandro G; DiMario F; Soffiati G; Scagnelli M; Bozzola L; Fabrello R; Valerio G
J Am Geriatr Soc; 1996 Jun; 44(6):665-70. PubMed ID: 8642157
[TBL] [Abstract][Full Text] [Related]
28. Serum pepsinogen values and Helicobacter pylori status among control subjects of a nested case-control study in the JACC study.
Kikuchi S; Yagyu K; Obata Y; Yingsong L; Yatsuya H; Hoshiyama Y; Kondo T; Sakata K; Mizoue T; Tokui N; Fujino Y; Tamakoshi A; Toyoshima H; Ishibashi T; Hayakawa N; Yoshimura T;
J Epidemiol; 2005 Jun; 15 Suppl 2(Suppl II):S126-33. PubMed ID: 16127224
[TBL] [Abstract][Full Text] [Related]
29. Association between serum pepsinogens and polymorphismof PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese.
Goto Y; Ando T; Yamamoto K; Tamakoshi A; El-Omar E; Goto H; Hamajima N
Int J Cancer; 2006 Jan; 118(1):203-8. PubMed ID: 16032704
[TBL] [Abstract][Full Text] [Related]
30. Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori.
Schlemper RJ; van der Werf SD; Vandenbroucke JP; Biemond I; Lamers CB
Gut; 1995 Aug; 37(2):199-204. PubMed ID: 7557568
[TBL] [Abstract][Full Text] [Related]
31. Predominant mucosal IL-8 mRNA expression in non-cagA Thais is risk for gastric cancer.
Yamada S; Kato S; Matsuhisa T; Makonkawkeyoon L; Yoshida M; Chakrabandhu T; Lertprasertsuk N; Suttharat P; Chakrabandhu B; Nishiumi S; Chongraksut W; Azuma T
World J Gastroenterol; 2013 May; 19(19):2941-9. PubMed ID: 23704827
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of IgG antibody titer against Helicobacter pylori.
Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
Helicobacter; 2009 Jun; 14(3):231-6. PubMed ID: 19702853
[TBL] [Abstract][Full Text] [Related]
33. Long-term follow-up of pepsinogen I/II ratio after eradication of Helicobacter pylori in patients who underwent endoscopic mucosal resection for gastric cancer.
Nam SY; Jeon SW; Lee HS; Kwon YH; Park H; Choi JW
Dig Liver Dis; 2017 May; 49(5):500-506. PubMed ID: 28057446
[TBL] [Abstract][Full Text] [Related]
34. Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels.
Yanaoka K; Oka M; Yoshimura N; Mukoubayashi C; Enomoto S; Iguchi M; Magari H; Utsunomiya H; Tamai H; Arii K; Yamamichi N; Fujishiro M; Takeshita T; Mohara O; Ichinose M
Int J Cancer; 2008 Aug; 123(4):917-26. PubMed ID: 18508314
[TBL] [Abstract][Full Text] [Related]
35. Helicobacter pylori infection, serum pepsinogens as markers of atrophic gastritis, and leukocyte telomere length: a population-based study.
Muhsen K; Sinnreich R; Merom D; Nassar H; Cohen D; Kark JD
Hum Genomics; 2019 Jul; 13(1):32. PubMed ID: 31331390
[TBL] [Abstract][Full Text] [Related]
36. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population.
Asaka M; Kimura T; Kudo M; Takeda H; Mitani S; Miyazaki T; Miki K; Graham DY
Gastroenterology; 1992 Mar; 102(3):760-6. PubMed ID: 1537513
[TBL] [Abstract][Full Text] [Related]
37. Helicobacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality.
Tsugane S; Kabuto M; Imai H; Gey F; Tei Y; Hanaoka T; Sugano K; Watanabe S
Cancer Causes Control; 1993 Jul; 4(4):297-305. PubMed ID: 8347778
[TBL] [Abstract][Full Text] [Related]
38. Helicobacter pylori blood biomarker for gastric cancer risk in East Asia.
Cai H; Ye F; Michel A; Murphy G; Sasazuki S; Taylor PR; Qiao YL; Park SK; Yoo KY; Jee SH; Cho ER; Kim J; Chen SC; Abnet CC; Tsugane S; Cai Q; Shu XO; Zheng W; Pawlita M; Epplein M
Int J Epidemiol; 2016 Jun; 45(3):774-81. PubMed ID: 27170766
[TBL] [Abstract][Full Text] [Related]
39. No association between AICDA 7888 C/T polymorphism, Helicobacter pylori seropositivity, and the risk of atrophic gastritis and gastric cancer in Japanese.
Hishida A; Matsuo K; Goto Y; Mitsuda Y; Hiraki A; Naito M; Wakai K; Tajima K; Hamajima N
Gastric Cancer; 2010 Mar; 13(1):43-9. PubMed ID: 20373075
[TBL] [Abstract][Full Text] [Related]
40. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.
Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O
J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
